Literature DB >> 12944421

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

Christopher A Haiman1, Daniel O Stram, Malcolm C Pike, Laurence N Kolonel, Noel P Burtt, David Altshuler, Joel Hirschhorn, Brian E Henderson.   

Abstract

The CYP19 gene encodes for aromatase (P450arom), a key steroidogenic enzyme that catalyzes the final step of estrogen biosynthesis. Apart from rare mutations in CYP19 which result in severe phenotypes associated with estrogen insufficiency, little is known about whether common variation in CYP19 is associated with risk of hormone-related diseases. In this study, we employed a haplotype-based approach to search for common disease-associated variants in this candidate breast cancer susceptibility gene among African-American, Hawaiian, Japanese, Latina and White women in the Multiethnic Cohort Study (MEC). We utilized 74 densely spaced single-nucleotide polymorphisms (SNPs) (one every approximately 2.6 kb) spanning 189.4 kb of the CYP19 locus to characterize linkage disequilibrium (LD) and haplotype patterns among 69-70 individuals from each ethnic population. We detected four regions of strong LD (blocks 1-4) that were quite closely conserved across populations. Within each block there was a limited diversity of common haplotypes (5 to 10 with a frequency >/=5%) and most haplotypes were observed to be shared across populations. Twenty-five haplotype-tagging SNPs (htSNPs) were selected to predict the common haplotypes with high probability (average Rh2=0.92) and genotyped in a breast cancer case-control study in the MEC (cases, n=1355; controls, n=2580). We first performed global tests for differences in risk according to the common haplotypes and observed significant haplotype-effects in block 2 [P=0.01; haplotypes 2b (OR=1.23; 95% CI, 1.07-1.40), 2d (OR=1.28; 95% CI, 1.01-1.62)]. We also found a common long-range haplotype comprised of block-specific haplotypes 2b and 3c to be associated with increased risk of breast cancer (haplotype 2b-3c: OR=1.31; 95% CI, 1.11-1.54). Our findings suggest the hypothesis that women with the long-range CYP19 haplotype 2b-3c may be carriers of a predisposing breast cancer susceptibility allele.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944421     DOI: 10.1093/hmg/ddg294

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  56 in total

1.  Genetic variation in the sex hormone metabolic pathway and endometriosis risk: an evaluation of candidate genes.

Authors:  Britton Trabert; Stephen M Schwartz; Ulrike Peters; Anneclaire J De Roos; Chu Chen; Delia Scholes; Victoria L Holt
Journal:  Fertil Steril       Date:  2011-09-28       Impact factor: 7.329

2.  Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19 may influence age at menarche: a genetic association study in Caucasian females.

Authors:  Yan Guo; Dong-Hai Xiong; Tie-Lin Yang; Yan-Fang Guo; Robert R Recker; Hong-Wen Deng
Journal:  Hum Mol Genet       Date:  2006-06-16       Impact factor: 6.150

3.  A genomewide admixture map for Latino populations.

Authors:  Alkes L Price; Nick Patterson; Fuli Yu; David R Cox; Alicja Waliszewska; Gavin J McDonald; Arti Tandon; Christine Schirmer; Julie Neubauer; Gabriel Bedoya; Constanza Duque; Alberto Villegas; Maria Catira Bortolini; Francisco M Salzano; Carla Gallo; Guido Mazzotti; Marcela Tello-Ruiz; Laura Riba; Carlos A Aguilar-Salinas; Samuel Canizales-Quinteros; Marta Menjivar; William Klitz; Brian Henderson; Christopher A Haiman; Cheryl Winkler; Teresa Tusie-Luna; Andres Ruiz-Linares; David Reich
Journal:  Am J Hum Genet       Date:  2007-04-13       Impact factor: 11.025

4.  Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.

Authors:  Veronica Wendy Setiawan; Jennifer A Doherty; Xiao-Ou Shu; Mohammad R Akbari; Chu Chen; Immaculata De Vivo; Angela Demichele; Montserrat Garcia-Closas; Marc T Goodman; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Pamela L Horn-Ross; James V Lacey; Loic Le Marchand; Douglas A Levine; Xiaolin Liang; Jolanta Lissowska; Galina Lurie; Monica McGrath; Steven A Narod; Timothy R Rebbeck; Giske Ursin; Noel S Weiss; Yong-Bing Xiang; Hannah P Yang; Wei Zheng; Sara H Olson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

5.  CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.

Authors:  Brian Leyland-Jones; Kathryn P Gray; Mark Abramovitz; Mark Bouzyk; Brandon Young; Bradley Long; Roswitha Kammler; Patrizia Dell'Orto; Maria Olivia Biasi; Beat Thürlimann; Maria B Lyng; Henrik J Ditzel; Vernon J Harvey; Patrick Neven; Isabelle Treilleux; Birgitte Bruun Rasmussen; Rudolf Maibach; Karen N Price; Alan S Coates; Aron Goldhirsch; Olivia Pagani; Giuseppe Viale; James M Rae; Meredith M Regan
Journal:  Breast Cancer Res Treat       Date:  2015-05-03       Impact factor: 4.872

6.  Re: the use of inferred haplotypes in downstream analysis.

Authors:  Peter Kraft; Daniel O Stram
Journal:  Am J Hum Genet       Date:  2007-10       Impact factor: 11.025

7.  Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India.

Authors:  Shilpi Chattopadhyay; Sarah Siddiqui; Md Salman Akhtar; Mohammad Zeeshan Najm; S V S Deo; N K Shukla; Syed Akhtar Husain
Journal:  Tumour Biol       Date:  2014-01-16

8.  Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.

Authors:  Marc T Goodman; Galina Lurie; Pamela J Thompson; Katharine E McDuffie; Michael E Carney
Journal:  Endocr Relat Cancer       Date:  2008-07-30       Impact factor: 5.678

9.  Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia.

Authors:  Barbara S Saltzman; Jennifer F Yamamoto; Robert Decker; Lance Yokochi; Andre G Theriault; Thomas M Vogt; Loïc Le Marchand
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

10.  Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.

Authors:  Carolyn J Crandall; Mary E Sehl; Sybil L Crawford; Ellen B Gold; Laurel A Habel; Lesley M Butler; Maryfran R Sowers; Gail A Greendale; Janet S Sinsheimer
Journal:  Breast Cancer Res       Date:  2009-07-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.